Taiyen Biotech Co (TPE:1737) Cyclically Adjusted FCF per Share: NT$1.18 (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TPE:1737 Taiyen Biotech Co Ltd TPE:1737
82 GF Score
Price NT$32.00
GF Value NT$32.05
Valuation Fairly Valued
! 1 Warning Sign
View Full Analysis

What is Taiyen Biotech Co Cyclically Adjusted FCF per Share?

Taiyen Biotech Co TPE:1737 +0.63% 82 Cyclically Adjusted FCF per Share is NT$1.18 as of Dec. 2025. GuruFocus rates TPE:1737 with a GF Score™ of 82/100 and a GF Value™ of NT$32.05 (Fairly Valued). The stock has 1 warning sign investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

Taiyen Biotech Co's adjusted free cash flow per share for the three months ended in Dec. 2025 was NT$0.266. Add all the adjusted free cash flow per share for the past 10 years together and divide the count will get our Cyclically Adjusted FCF per Share, which is NT$1.18 for the trailing ten years ended in Dec. 2025.

During the past 12 months, Taiyen Biotech Co's average Cyclically Adjusted FCF Growth Rate was -7.80% per year. During the past 3 years, the average Cyclically Adjusted FCF Growth Rate was 0.30% per year. During the past 5 years, the average Cyclically Adjusted FCF Growth Rate was 6.70% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted FCF Growth Rate using Cyclically Adjusted FCF per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted FCF Growth Rate of Taiyen Biotech Co was 10.70% per year. The lowest was 0.30% per year. And the median was 8.65% per year.

As of today (2026-07-23), Taiyen Biotech Co's current stock price is NT$32.00. Taiyen Biotech Co's Cyclically Adjusted FCF per Share for the quarter that ended in Dec. 2025 was NT$1.18. Taiyen Biotech Co's Cyclically Adjusted Price-to-FCF of today is 27.12.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of Taiyen Biotech Co was 43.33. The lowest was 24.43. And the median was 28.50.


Taiyen Biotech Co  (TPE:1737) Cyclically Adjusted FCF per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted FCF per Share may underestimate the company's free cash flow. Cyclically Adjusted Price-to-FCF can seem to be too high even the actual Price-to-Free-Cash-Flow is low.

For the Cyclically Adjusted Price-to-FCF, the free cash flow per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/FCF calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted Price-to-FCF is also called CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.

Taiyen Biotech Co's Cyclically Adjusted Price-to-FCF of today is calculated as

Cyclically Adjusted Price-to-FCF=Share Price/Cyclically Adjusted FCF per Share
=32.00/1.18
=27.12

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of Taiyen Biotech Co was 43.33. The lowest was 24.43. And the median was 28.50.


Be Aware

Cyclically Adjusted Price-to-FCF works better for cyclical companies. It gives you a better idea on the company's real free cash flow value.


Taiyen Biotech Co Cyclically Adjusted FCF per Share Related Terms


Taiyen Biotech Co Cyclically Adjusted FCF per Share Historical Data

* Premium members only.

The historical data trend for Taiyen Biotech Co's Cyclically Adjusted FCF per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Taiyen Biotech Co Cyclically Adjusted FCF per Share Chart

Taiyen Biotech Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted FCF per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.96 1.17 1.22 1.28 1.18

Taiyen Biotech Co Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25
Cyclically Adjusted FCF per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.28 1.24 1.29 1.22 1.18

TPE:1737 vs PG, CL, KVUE: Cyclically Adjusted FCF per Share Comparison

For the Household & Personal Products subindustry, Taiyen Biotech Co's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Taiyen Biotech Co Cyclically Adjusted Price-to-FCF vs Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, Taiyen Biotech Co's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Taiyen Biotech Co's Cyclically Adjusted Price-to-FCF falls into.


TPE:1737
82GF Score
Taiyen Biotech Co Ltd TPE:1737
Cyclically Adjusted FCF per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Taiyen Biotech Co Cyclically Adjusted FCF per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

What is Cyclically Adjusted FCF per Share? How do we calculate Cyclically Adjusted FCF per Share?

Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted FCF per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the free cash flow per share from 2001 through 2010.

We adjusted the 2001 free cash flow per share data with the total inflation from 2001 through 2010 to the equivalent free cash flow in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's free cash flow is $1 a share in 2001, then the 2001's equivalent free cash flow in 2010 is $1.4 a share. If Wal-Mart's free cash flow is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 free cash flow in 2010 is $1.35. So on and so forth, you get the equivalent free cash flow per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Taiyen Biotech Co's adjusted Free Cash Flow per Share data for the three months ended in Dec. 2025 was:

Adj_FreeCashFlowPerShare= Free Cash Flow per Share /CPI of Dec. 2025 (Change)*Current CPI (Dec. 2025)
=0.266/324.0540*324.0540
=0.266

Current CPI (Dec. 2025) = 324.0540.

Taiyen Biotech Co Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201603 0.529 238.132 0.720
201606 0.516 241.018 0.694
201609 0.537 241.428 0.721
201612 0.304 241.432 0.408
201703 0.533 243.801 0.708
201706 0.277 244.955 0.366
201709 0.529 246.819 0.695
201712 -0.150 246.524 -0.197
201803 -0.654 249.554 -0.849
201806 0.461 251.989 0.593
201809 0.649 252.439 0.833
201812 0.339 251.233 0.437
201903 -0.187 254.202 -0.238
201906 0.311 256.143 0.393
201909 -0.238 256.759 -0.300
201912 0.336 256.974 0.424
202003 -0.106 258.115 -0.133
202006 0.073 257.797 0.092
202009 0.494 260.280 0.615
202012 -0.104 260.474 -0.129
202103 0.043 264.877 0.053
202106 0.323 271.696 0.385
202109 -1.276 274.310 -1.507
202112 1.952 278.802 2.269
202203 -0.756 287.504 -0.852
202206 -0.632 296.311 -0.691
202209 3.082 296.808 3.365
202212 -0.036 296.797 -0.039
202303 0.064 301.836 0.069
202306 -0.040 305.109 -0.042
202309 0.109 307.789 0.115
202312 0.411 306.746 0.434
202403 0.126 312.332 0.131
202406 0.136 314.175 0.140
202409 0.465 315.301 0.478
202412 1.017 315.605 1.044
202503 -0.388 319.799 -0.393
202506 0.783 322.561 0.787
202509 -0.022 324.800 -0.022
202512 0.266 324.054 0.266

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

What does a Cyclically Adjusted FCF per Share of NT$1.18 mean?
Taiyen Biotech Co (TPE:1737) has a Cyclically Adjusted FCF per Share of NT$1.18 as of Dec. 2025. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on Taiyen Biotech Co and its competitors.
Is Taiyen Biotech Co's Cyclically Adjusted FCF per Share too high?
Taiyen Biotech Co's current Cyclically Adjusted FCF per Share is NT$1.18. Overall, Taiyen Biotech Co has a GF Score™ of 82/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Taiyen Biotech Co's Cyclically Adjusted FCF per Share compare to PG and CL?
Taiyen Biotech Co's Cyclically Adjusted FCF per Share of NT$1.18 can be compared against companies in the Consumer Packaged Goods industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted FCF per Share for a Consumer Packaged Goods company?
A good Cyclically Adjusted FCF per Share depends on the Consumer Packaged Goods industry context. However, Cyclically Adjusted FCF per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted FCF per Share mean?
A high Cyclically Adjusted FCF per Share can signal that a stock is expensive relative to its fundamentals. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on Taiyen Biotech Co and its competitors. Taiyen Biotech Co's current Cyclically Adjusted FCF per Share is NT$1.18. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Taiyen Biotech Co stock overvalued right now?
Based on GuruFocus' analysis, Taiyen Biotech Co (TPE:1737) is currently considered Fairly Valued. The stock's GF Value™ is NT$32.05, compared to a current price of NT$32.00 — trading 0.2% below its estimated fair value. The current Cyclically Adjusted FCF per Share is NT$1.18. Taiyen Biotech Co's overall GF Score™ is 82/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted FCF per Share calculated?
Cyclically Adjusted FCF per Share is calculated from a company's financial statements. For Taiyen Biotech Co (TPE:1737), the current Cyclically Adjusted FCF per Share is NT$1.18 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Taiyen Biotech Co (TPE:1737) Overvalued in 2026?

Based on GuruFocus' analysis, Taiyen Biotech Co stock appears to be undervalued. The current stock price of NT$32.00 is trading 0.2% below its estimated GF Value™ of NT$32.05. GuruFocus considers Taiyen Biotech Co to be Fairly Valued.

Key valuation signals for TPE:1737:

  • Cyclically Adjusted FCF per Share: NT$1.18
  • GF Value™: NT$32.05 vs. price of NT$32.00 (0.2% below fair value)
  • GF Score™: 82/100 with 1 warning sign

No single metric tells the full story. See the TPE:1737 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Taiyen Biotech Co Business Description

Address No. 297, Section 1, Chien-Kang Road, South District, Tainan, TWN
Taiyen Biotech Co Ltd operates in personal care and home care products. Its product portfolio comprises beauty care products, health food, skin products, salt products and spices, bottled water, and medical supplies, among others. The group has four reportable segments; Salt products and packaged water department, Biotech cleaning and maintenance department, Construction and services department, and Other departments.. The Salt and Packaged Product Segment accounts for the bulk of revenue. Geographically it operates through the region of Taiwan; however, it also holds a presence in the international market.
82GF Score

Get the complete analysis for TPE:1737

Cyclically Adjusted FCF per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$32.00
Price
NT$32.05
GF Value